Emerging PBC Pruritus Therapies
Emerging Therapies for Pruritus in PBC

Released: December 18, 2024

Expiration: December 17, 2025

Stuart C. Gordon
Stuart C. Gordon, MD
Marlyn J. Mayo
Marlyn J. Mayo, MD
Pam Rivard
Pam Rivard, RN

Activity

Progress
1
Course Completed

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.

Listen as they discuss:

  • Gaps in current management
  • Patient perspectives: why we should not dismiss itching as an underlying psychologic problem
  • PPAR agonists and how they affect pruritus
    • BEZURSO and FITCH
    • ELATIVE
    • ENHANCE and RESPONSE
  • IBATs (inhibitors of bile acid transport)
    • GLIMMER
  • Common questions